1. Home
  2. PTGX vs SYBT Comparison

PTGX vs SYBT Comparison

Compare PTGX & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • SYBT
  • Stock Information
  • Founded
  • PTGX 2006
  • SYBT 1904
  • Country
  • PTGX United States
  • SYBT United States
  • Employees
  • PTGX N/A
  • SYBT N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • SYBT Major Banks
  • Sector
  • PTGX Health Care
  • SYBT Finance
  • Exchange
  • PTGX Nasdaq
  • SYBT Nasdaq
  • Market Cap
  • PTGX 2.3B
  • SYBT 2.2B
  • IPO Year
  • PTGX 2016
  • SYBT N/A
  • Fundamental
  • Price
  • PTGX $38.75
  • SYBT $72.94
  • Analyst Decision
  • PTGX Strong Buy
  • SYBT Hold
  • Analyst Count
  • PTGX 8
  • SYBT 4
  • Target Price
  • PTGX $57.13
  • SYBT $65.25
  • AVG Volume (30 Days)
  • PTGX 528.6K
  • SYBT 152.8K
  • Earning Date
  • PTGX 02-21-2025
  • SYBT 01-22-2025
  • Dividend Yield
  • PTGX N/A
  • SYBT 1.70%
  • EPS Growth
  • PTGX N/A
  • SYBT 5.99
  • EPS
  • PTGX 4.23
  • SYBT 3.89
  • Revenue
  • PTGX $434,433,000.00
  • SYBT $342,545,000.00
  • Revenue This Year
  • PTGX $445.33
  • SYBT N/A
  • Revenue Next Year
  • PTGX N/A
  • SYBT $5.94
  • P/E Ratio
  • PTGX $9.16
  • SYBT $18.75
  • Revenue Growth
  • PTGX 624.05
  • SYBT 5.57
  • 52 Week Low
  • PTGX $24.22
  • SYBT $42.35
  • 52 Week High
  • PTGX $48.89
  • SYBT $79.79
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 52.47
  • SYBT 44.04
  • Support Level
  • PTGX $37.50
  • SYBT $73.72
  • Resistance Level
  • PTGX $39.37
  • SYBT $75.97
  • Average True Range (ATR)
  • PTGX 1.32
  • SYBT 2.08
  • MACD
  • PTGX 0.16
  • SYBT -0.29
  • Stochastic Oscillator
  • PTGX 67.70
  • SYBT 24.14

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates a majority of its revenue from the Commercial Banking segment.

Share on Social Networks: